We reported a point mutation in CHRNA1 encoding the acetylcholine receptor (AChR) α subunit in a patient with CMS, which switches binding of a splicing-suppressing RNA-binding protein hnRNP L to a splicing-enhancing RNA-binding protein hnRNP LL35. This evidence concerns the gene HNRNPL and congenital myasthenic syndrome.